Cargando…

Management of IgA Nephropathy in Pediatric Patients

The onset of IgA nephritis in childhood and adolescence often develops into chronic glomerulonephritis with declining renal function. Although these long-term consequences are known, there is still a lack of evidence-based treatment recommendations in this age group. We report data from 22 pediatric...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroda, Sophie, Pohl, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139388/
https://www.ncbi.nlm.nih.gov/pubmed/35626829
http://dx.doi.org/10.3390/children9050653
_version_ 1784714848067649536
author Schroda, Sophie
Pohl, Martin
author_facet Schroda, Sophie
Pohl, Martin
author_sort Schroda, Sophie
collection PubMed
description The onset of IgA nephritis in childhood and adolescence often develops into chronic glomerulonephritis with declining renal function. Although these long-term consequences are known, there is still a lack of evidence-based treatment recommendations in this age group. We report data from 22 pediatric patients who were biopsied to confirm the diagnosis of IgAN at our clinical center. 14 of them were treated with corticosteroids according to the recommendations for IgA nephritis vasculitis of the German Society of Pediatric Nephrology (GPN). Improvement was achieved in the majority of all cases, with a significant reduction in proteinuria five months after initiation of therapy. Our data suggest that treatment regimens for acute IgA nephritis and IgA vasculitis nephritis may be unified and are discussed in the context of current studies.
format Online
Article
Text
id pubmed-9139388
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91393882022-05-28 Management of IgA Nephropathy in Pediatric Patients Schroda, Sophie Pohl, Martin Children (Basel) Article The onset of IgA nephritis in childhood and adolescence often develops into chronic glomerulonephritis with declining renal function. Although these long-term consequences are known, there is still a lack of evidence-based treatment recommendations in this age group. We report data from 22 pediatric patients who were biopsied to confirm the diagnosis of IgAN at our clinical center. 14 of them were treated with corticosteroids according to the recommendations for IgA nephritis vasculitis of the German Society of Pediatric Nephrology (GPN). Improvement was achieved in the majority of all cases, with a significant reduction in proteinuria five months after initiation of therapy. Our data suggest that treatment regimens for acute IgA nephritis and IgA vasculitis nephritis may be unified and are discussed in the context of current studies. MDPI 2022-05-02 /pmc/articles/PMC9139388/ /pubmed/35626829 http://dx.doi.org/10.3390/children9050653 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Schroda, Sophie
Pohl, Martin
Management of IgA Nephropathy in Pediatric Patients
title Management of IgA Nephropathy in Pediatric Patients
title_full Management of IgA Nephropathy in Pediatric Patients
title_fullStr Management of IgA Nephropathy in Pediatric Patients
title_full_unstemmed Management of IgA Nephropathy in Pediatric Patients
title_short Management of IgA Nephropathy in Pediatric Patients
title_sort management of iga nephropathy in pediatric patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139388/
https://www.ncbi.nlm.nih.gov/pubmed/35626829
http://dx.doi.org/10.3390/children9050653
work_keys_str_mv AT schrodasophie managementofiganephropathyinpediatricpatients
AT pohlmartin managementofiganephropathyinpediatricpatients